3.23.1 html 419 468 1 false 122 0 false 9 false false R1.htm 0001 - Document - Document And Entity Information Sheet http://www.fsdpharma.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 0002 - Statement - CONSOLIDATED STATEMENTS OF FINANCIAL POSITION Sheet http://www.fsdpharma.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION CONSOLIDATED STATEMENTS OF FINANCIAL POSITION Statements 2 false false R3.htm 0003 - Statement - CONSOLIDATED STATEMENTS OF LOSS AND COMPREHENSIVE LOSS Sheet http://www.fsdpharma.com/role/CONSOLIDATEDSTATEMENTSOFLOSSANDCOMPREHENSIVELOSS CONSOLIDATED STATEMENTS OF LOSS AND COMPREHENSIVE LOSS Statements 3 false false R4.htm 0004 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDER'S EQUITY Sheet http://www.fsdpharma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDER'S EQUITY Statements 4 false false R5.htm 0005 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.fsdpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 5 false false R6.htm 0006 - Disclosure - Nature of business Sheet http://www.fsdpharma.com/role/NatureOfBusiness Nature of business Notes 6 false false R7.htm 0007 - Disclosure - Basis of presentation Sheet http://www.fsdpharma.com/role/BasisOfPresentation Basis of presentation Notes 7 false false R8.htm 0008 - Disclosure - Significant accounting policies Sheet http://www.fsdpharma.com/role/SignificantAccountingPolicies Significant accounting policies Notes 8 false false R9.htm 0009 - Disclosure - Acquisition of Lucid Sheet http://www.fsdpharma.com/role/AcquisitionOfLucid Acquisition of Lucid Notes 9 false false R10.htm 0010 - Disclosure - Assets held for sale Sheet http://www.fsdpharma.com/role/AssetsHeldForSale Assets held for sale Notes 10 false false R11.htm 0011 - Disclosure - Other receivables Sheet http://www.fsdpharma.com/role/TradeAndOtherReceivables Other receivables Notes 11 false false R12.htm 0012 - Disclosure - Prepaid expenses and deposits Sheet http://www.fsdpharma.com/role/PrepaidExpensesAndDeposits Prepaid expenses and deposits Notes 12 false false R13.htm 0013 - Disclosure - Finance receivables Sheet http://www.fsdpharma.com/role/FinanceReceivables Finance receivables Notes 13 false false R14.htm 0014 - Disclosure - Investments Sheet http://www.fsdpharma.com/role/OtherInvestments Investments Notes 14 false false R15.htm 0015 - Disclosure - Right-of-use asset Sheet http://www.fsdpharma.com/role/RightofuseAsset Right-of-use asset Notes 15 false false R16.htm 0016 - Disclosure - Intangible assets Sheet http://www.fsdpharma.com/role/IntangibleAssets Intangible assets Notes 16 false false R17.htm 0017 - Disclosure - Trade and other payables Sheet http://www.fsdpharma.com/role/TradeAndOtherPayables Trade and other payables Notes 17 false false R18.htm 0018 - Disclosure - Lease obligations Sheet http://www.fsdpharma.com/role/LeaseObligations Lease obligations Notes 18 false false R19.htm 0019 - Disclosure - Warrants Liability Sheet http://www.fsdpharma.com/role/WarrantsLiability Warrants Liability Notes 19 false false R20.htm 0020 - Disclosure - Share capital Sheet http://www.fsdpharma.com/role/ShareCapital Share capital Notes 20 false false R21.htm 0021 - Disclosure - Share-based compensation Sheet http://www.fsdpharma.com/role/SharebasedCompensation Share-based compensation Notes 21 false false R22.htm 0022 - Disclosure - Loss per share Sheet http://www.fsdpharma.com/role/LossPerShare Loss per share Notes 22 false false R23.htm 0023 - Disclosure - General and administrative Sheet http://www.fsdpharma.com/role/GeneralAndAdministrative General and administrative Notes 23 false false R24.htm 0024 - Disclosure - Segment information Sheet http://www.fsdpharma.com/role/SegmentedInformation Segment information Notes 24 false false R25.htm 0025 - Disclosure - Income Taxes Sheet http://www.fsdpharma.com/role/IncomeTaxes Income Taxes Notes 25 false false R26.htm 0026 - Disclosure - Commitments and contingencies Sheet http://www.fsdpharma.com/role/CommitmentsAndContingencies Commitments and contingencies Notes 26 false false R27.htm 0027 - Disclosure - Related party transactions Sheet http://www.fsdpharma.com/role/RelatedPartyTransactions Related party transactions Notes 27 false false R28.htm 0028 - Disclosure - Capital Management Sheet http://www.fsdpharma.com/role/CapitalManagement Capital Management Notes 28 false false R29.htm 0029 - Disclosure - Financial Instruments and Risk Management Sheet http://www.fsdpharma.com/role/FinancialInstrumentsAndRiskManagement Financial Instruments and Risk Management Notes 29 false false R30.htm 0030 - Disclosure - Subsequent events Sheet http://www.fsdpharma.com/role/SubsequentEvents Subsequent events Notes 30 false false R31.htm 0031 - Disclosure - Significant accounting policies (Policies) Sheet http://www.fsdpharma.com/role/SignificantAccountingPoliciesPolicies Significant accounting policies (Policies) Policies 31 false false R32.htm 0032 - Disclosure - Nature of business (Tables) Sheet http://www.fsdpharma.com/role/NatureOfBusinessTable Nature of business (Tables) Tables http://www.fsdpharma.com/role/NatureOfBusiness 32 false false R33.htm 0033 - Disclosure - Significant accounting policies (Tables) Sheet http://www.fsdpharma.com/role/SignificantAccountingPoliciesTables Significant accounting policies (Tables) Tables http://www.fsdpharma.com/role/SignificantAccountingPolicies 33 false false R34.htm 0034 - Disclosure - Acquisition of Lucid (Tables) Sheet http://www.fsdpharma.com/role/AcquisitionOfLucidTables Acquisition of Lucid (Tables) Tables http://www.fsdpharma.com/role/AcquisitionOfLucid 34 false false R35.htm 0035 - Disclosure - Assets held for sale (Tables) Sheet http://www.fsdpharma.com/role/AssetsHeldForSaleTables Assets held for sale (Tables) Tables http://www.fsdpharma.com/role/AssetsHeldForSale 35 false false R36.htm 0036 - Disclosure - Other receivables (Tables) Sheet http://www.fsdpharma.com/role/TradeAndOtherReceivablesTables Other receivables (Tables) Tables http://www.fsdpharma.com/role/TradeAndOtherReceivables 36 false false R37.htm 0037 - Disclosure - Prepaid expenses and deposits (Tables) Sheet http://www.fsdpharma.com/role/PrepaidExpensesAndDepositsTables Prepaid expenses and deposits (Tables) Tables http://www.fsdpharma.com/role/PrepaidExpensesAndDeposits 37 false false R38.htm 0038 - Disclosure - Finance receivables (Tables) Sheet http://www.fsdpharma.com/role/FinanceReceivablesTables Finance receivables (Tables) Tables http://www.fsdpharma.com/role/FinanceReceivables 38 false false R39.htm 0039 - Disclosure - Investments (Tables) Sheet http://www.fsdpharma.com/role/OtherinvestmentsTables Investments (Tables) Tables http://www.fsdpharma.com/role/OtherInvestments 39 false false R40.htm 0040 - Disclosure - Right-of-use asset (Tables) Sheet http://www.fsdpharma.com/role/RightofuseAssetTables Right-of-use asset (Tables) Tables http://www.fsdpharma.com/role/RightofuseAsset 40 false false R41.htm 0041 - Disclosure - Intangible assets (Tables) Sheet http://www.fsdpharma.com/role/IntangibleAssetsTables Intangible assets (Tables) Tables http://www.fsdpharma.com/role/IntangibleAssets 41 false false R42.htm 0042 - Disclosure - Trade and other payables (Tables) Sheet http://www.fsdpharma.com/role/TradeAndOtherPayablesTables Trade and other payables (Tables) Tables http://www.fsdpharma.com/role/TradeAndOtherPayables 42 false false R43.htm 0043 - Disclosure - Lease obligations (Tables) Sheet http://www.fsdpharma.com/role/LeaseObligationsTables Lease obligations (Tables) Tables http://www.fsdpharma.com/role/LeaseObligations 43 false false R44.htm 0044 - Disclosure - Share capital (Tables) Sheet http://www.fsdpharma.com/role/ShareCapitalTables Share capital (Tables) Tables http://www.fsdpharma.com/role/ShareCapital 44 false false R45.htm 0045 - Disclosure - Share-based compensation (Tables) Sheet http://www.fsdpharma.com/role/SharebasedCompensationTables Share-based compensation (Tables) Tables http://www.fsdpharma.com/role/SharebasedCompensation 45 false false R46.htm 0046 - Disclosure - Loss per share (Tables) Sheet http://www.fsdpharma.com/role/LossPerShareTables Loss per share (Tables) Tables http://www.fsdpharma.com/role/LossPerShare 46 false false R47.htm 0047 - Disclosure - General and administrative (Tables) Sheet http://www.fsdpharma.com/role/GeneralAndAdministrativeTables General and administrative (Tables) Tables http://www.fsdpharma.com/role/GeneralAndAdministrative 47 false false R48.htm 0048 - Disclosure - Segment information (Tables) Sheet http://www.fsdpharma.com/role/SegmentInformation Segment information (Tables) Tables http://www.fsdpharma.com/role/SegmentedInformation 48 false false R49.htm 0049 - Disclosure - Income Taxes (Tables) Sheet http://www.fsdpharma.com/role/IncometaxesTables Income Taxes (Tables) Tables http://www.fsdpharma.com/role/IncomeTaxes 49 false false R50.htm 0051 - Disclosure - Related party transactions (Tables) Sheet http://www.fsdpharma.com/role/RelatedPartyTransactionsTables Related party transactions (Tables) Tables http://www.fsdpharma.com/role/RelatedPartyTransactions 50 false false R51.htm 0052 - Disclosure - Nature of business - Schedule of ownership percentage in subsidiaries (Details) Sheet http://www.fsdpharma.com/role/NatureOfBusinessScheduleOfOwnershipPercentageInSubsidiariesDetails Nature of business - Schedule of ownership percentage in subsidiaries (Details) Details 51 false false R52.htm 0053 - Disclosure - Significant accounting policies - Schedule of estimated useful lives of assets (Details) Sheet http://www.fsdpharma.com/role/SignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfAssetsDetails Significant accounting policies - Schedule of estimated useful lives of assets (Details) Details 52 false false R53.htm 0054 - Disclosure - Acquisition of Lucid (Narrative) (Details) Sheet http://www.fsdpharma.com/role/AcquisitionOfLucidDetailTextuals Acquisition of Lucid (Narrative) (Details) Details http://www.fsdpharma.com/role/AcquisitionOfLucidTables 53 false false R54.htm 0055 - Disclosure - Acquisition of Lucid - Schedule of Black Scholes options pricing model (Details) Sheet http://www.fsdpharma.com/role/AcquisitionOfLucidDetails Acquisition of Lucid - Schedule of Black Scholes options pricing model (Details) Details 54 false false R55.htm 0056 - Disclosure - Acquisition of Lucid - Schedule of identifiable assets acquired and liabilities assumed (Details) Sheet http://www.fsdpharma.com/role/AcquisitionOfLucidDetails1 Acquisition of Lucid - Schedule of identifiable assets acquired and liabilities assumed (Details) Details 55 false false R56.htm 0057 - Disclosure - Assets held for sale (Narrative) (Details) Sheet http://www.fsdpharma.com/role/AssetsHeldForSaleDetailTextuals Assets held for sale (Narrative) (Details) Details http://www.fsdpharma.com/role/AssetsHeldForSaleTables 56 false false R57.htm 0058 - Disclosure - Assets held for sale - Schedule of components of assets held for sale (Details) Sheet http://www.fsdpharma.com/role/AssetsHeldForSaleDetails Assets held for sale - Schedule of components of assets held for sale (Details) Details 57 false false R58.htm 0059 - Disclosure - Assets held for sale - Schedule of net loss and comprehensive loss from discontinued operations (Details) Sheet http://www.fsdpharma.com/role/AssetsHeldForSaleDetails1 Assets held for sale - Schedule of net loss and comprehensive loss from discontinued operations (Details) Details 58 false false R59.htm 0060 - Disclosure - Assets held for sale - Schedule of cash flows from discontinued operations (Details) Sheet http://www.fsdpharma.com/role/AssetsHeldForSaleDetails2 Assets held for sale - Schedule of cash flows from discontinued operations (Details) Details 59 false false R60.htm 0061 - Disclosure - Other receivables - Schedule of other receivables (Details) Sheet http://www.fsdpharma.com/role/TradeAndOtherReceivablesScheduleOfTradeAndOtherReceivablesDetails Other receivables - Schedule of other receivables (Details) Details 60 false false R61.htm 0062 - Disclosure - Prepaid expenses and deposits - Schedule of prepaid expenses and deposits (Details) Sheet http://www.fsdpharma.com/role/PrepaidExpensesAndDepositsDetails Prepaid expenses and deposits - Schedule of prepaid expenses and deposits (Details) Details 61 false false R62.htm 0063 - Disclosure - Finance receivables - Schedule of finance receivables (Details) Sheet http://www.fsdpharma.com/role/FinanceReceivablesDetails Finance receivables - Schedule of finance receivables (Details) Details 62 false false R63.htm 0064 - Disclosure - Finance receivables - Schedule of finance receivable, net (Details) Sheet http://www.fsdpharma.com/role/FinanceReceivablesDetails1 Finance receivables - Schedule of finance receivable, net (Details) Details 63 false false R64.htm 0065 - Disclosure - Investments (Narrative) (Details) Sheet http://www.fsdpharma.com/role/OtherInvestmentsNarrativeDetails Investments (Narrative) (Details) Details http://www.fsdpharma.com/role/OtherinvestmentsTables 64 false false R65.htm 0066 - Disclosure - Investments - Schedule of investments (Details) Sheet http://www.fsdpharma.com/role/OtherInvestmentsScheduleOfOtherInvestmentsDetails Investments - Schedule of investments (Details) Details 65 false false R66.htm 0067 - Disclosure - Right-of-use asset - Schedule of right-of-use asset (Details) Sheet http://www.fsdpharma.com/role/RightofuseAssetScheduleOfRightofuseAssetDetails Right-of-use asset - Schedule of right-of-use asset (Details) Details 66 false false R67.htm 0068 - Disclosure - Intangible assets (Narrative) (Details) Sheet http://www.fsdpharma.com/role/IntangibleAssetsNarrativeDetails Intangible assets (Narrative) (Details) Details http://www.fsdpharma.com/role/IntangibleAssetsTables 67 false false R68.htm 0069 - Disclosure - Intangible assets - Schedule of intangible assets (Details) Sheet http://www.fsdpharma.com/role/IntangibleAssetsScheduleOfIntangibleAssetsDetails Intangible assets - Schedule of intangible assets (Details) Details 68 false false R69.htm 0070 - Disclosure - Trade and other payables - Schedule of trade and other payables (Details) Sheet http://www.fsdpharma.com/role/TradeAndOtherPayablesDetails Trade and other payables - Schedule of trade and other payables (Details) Details 69 false false R70.htm 0071 - Disclosure - Trade and other payables - Schedule of accrued liabilities (Details) Sheet http://www.fsdpharma.com/role/TradeAndOtherPayablesDetails1 Trade and other payables - Schedule of accrued liabilities (Details) Details 70 false false R71.htm 0072 - Disclosure - Lease obligations - Schedule of lease obligations (Details) Sheet http://www.fsdpharma.com/role/LeaseObligationsScheduleOfLeaseObligationsDetails Lease obligations - Schedule of lease obligations (Details) Details 71 false false R72.htm 0073 - Disclosure - Lease obligations - Schedule of maturity analysis of operating lease payments (Details) Sheet http://www.fsdpharma.com/role/LeaseObligationsScheduleOfMaturityAnalysisOfOperatingLeasePaymentsDetails Lease obligations - Schedule of maturity analysis of operating lease payments (Details) Details 72 false false R73.htm 0074 - Disclosure - Warrants Liability (Narrative) (Details) Sheet http://www.fsdpharma.com/role/WarrantsLiabilityDetailTextuals Warrants Liability (Narrative) (Details) Details http://www.fsdpharma.com/role/WarrantsLiability 73 false false R74.htm 0075 - Disclosure - Share capital (Narrative) (Details) Sheet http://www.fsdpharma.com/role/ShareCapitalNarrativeDetails Share capital (Narrative) (Details) Details http://www.fsdpharma.com/role/ShareCapitalTables 74 false false R75.htm 0076 - Disclosure - Share capital - Schedule of reconciliation of the share capital (Details) Sheet http://www.fsdpharma.com/role/ShareCapitalScheduleOfReconciliationOfTheShareCapitalDetails Share capital - Schedule of reconciliation of the share capital (Details) Details 75 false false R76.htm 0077 - Disclosure - Share capital - Schedule of changes in number of warrants outstanding (Details) Sheet http://www.fsdpharma.com/role/ShareCapitalScheduleOfChangesInNumberOfWarrantsOutstandingDetails Share capital - Schedule of changes in number of warrants outstanding (Details) Details 76 false false R77.htm 0078 - Disclosure - Share capital - Schedule of fair value assumptions of warrants (Details) Sheet http://www.fsdpharma.com/role/ShareCapitalScheduleOfFairValueAssumptionsOfWarrantsDetails Share capital - Schedule of fair value assumptions of warrants (Details) Details 77 false false R78.htm 0079 - Disclosure - Share capital - Schedule of warrants outstanding and exercise price (Details) Sheet http://www.fsdpharma.com/role/ShareCapitalScheduleOfWarrantsOutstandingAndExercisePriceDetails Share capital - Schedule of warrants outstanding and exercise price (Details) Details 78 false false R79.htm 0080 - Disclosure - Share-based compensation (Narrative) (Details) Sheet http://www.fsdpharma.com/role/SharebasedCompensationNarrativeDetails Share-based compensation (Narrative) (Details) Details http://www.fsdpharma.com/role/SharebasedCompensationTables 79 false false R80.htm 0081 - Disclosure - Share-based compensation - Schedule of changes in number of share options (Details) Sheet http://www.fsdpharma.com/role/SharebasedCompensationScheduleOfChangesInNumberOfShareOptionsDetails Share-based compensation - Schedule of changes in number of share options (Details) Details 80 false false R81.htm 0082 - Disclosure - Share-based compensation - Schedule of fair value assumptions of share options granted (Details) Sheet http://www.fsdpharma.com/role/SharebasedCompensationScheduleOfFairValueAssumptionsOfShareOptionsGrantedDetails Share-based compensation - Schedule of fair value assumptions of share options granted (Details) Details 81 false false R82.htm 0083 - Disclosure - Share-based compensation - Schedule of exercise price and weighted average contractual term of share options outstanding and exercisable (Details) Sheet http://www.fsdpharma.com/role/SharebasedCompensationScheduleOfExercisePriceAndWeightedAverageContractualTermOfShareOptionsOutstandingAndExercisableDetails Share-based compensation - Schedule of exercise price and weighted average contractual term of share options outstanding and exercisable (Details) Details 82 false false R83.htm 0084 - Disclosure - Share-based compensation - Schedule of change in number of performance share unit (Details) Sheet http://www.fsdpharma.com/role/SharebasedCompensationScheduleOfFairValueAssumptionsOfNumberOfPerformanceShareUnitGrantedDetails Share-based compensation - Schedule of change in number of performance share unit (Details) Details 83 false false R84.htm 0085 - Disclosure - Share-based compensation - Schedule of fair value assumptions of Performance based payment (Details) Sheet http://www.fsdpharma.com/role/SharebasedCompensationScheduleOfFairValueAssumptionsOfPerformanceBasedPaymentDetails Share-based compensation - Schedule of fair value assumptions of Performance based payment (Details) Details 84 false false R85.htm 0086 - Disclosure - Share-based compensation - Schedule of share-based compensation (Details) Sheet http://www.fsdpharma.com/role/SharebasedCompensationScheduleOfSharebasedCompensationDetails Share-based compensation - Schedule of share-based compensation (Details) Details 85 false false R86.htm 0087 - Disclosure - Loss per share - Schedule of loss per share (Details) Sheet http://www.fsdpharma.com/role/LossPerShareDetails Loss per share - Schedule of loss per share (Details) Details 86 false false R87.htm 0088 - Disclosure - General and administrative - Schedule of general and administrative expense (Details) Sheet http://www.fsdpharma.com/role/GeneralAndAdministrativeDetails General and administrative - Schedule of general and administrative expense (Details) Details 87 false false R88.htm 0089 - Disclosure - Segment information (Schedule of asset and income by segment) (Details) Sheet http://www.fsdpharma.com/role/SegmentInformationNarrativeDetails Segment information (Schedule of asset and income by segment) (Details) Details http://www.fsdpharma.com/role/SegmentInformation 88 false false R89.htm 0090 - Disclosure - Income Taxes (Narrative) (Details) Sheet http://www.fsdpharma.com/role/IncomeTaxesNarrativeDetails Income Taxes (Narrative) (Details) Details http://www.fsdpharma.com/role/IncometaxesTables 89 false false R90.htm 0091 - Disclosure - Income Taxes - Schedule of provision for income taxes (Details) Sheet http://www.fsdpharma.com/role/IncomeTaxesScheduleOfProvisionForIncomeTaxesDetails Income Taxes - Schedule of provision for income taxes (Details) Details 90 false false R91.htm 0092 - Disclosure - Income Taxes - Schedule of deferred tax assets (liabilities) (Details) Sheet http://www.fsdpharma.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsLiabilitiesDetails Income Taxes - Schedule of deferred tax assets (liabilities) (Details) Details 91 false false R92.htm 0093 - Disclosure - Income Taxes - Schedule of temporary differences for which deferred tax assets not recognised (Details) Sheet http://www.fsdpharma.com/role/IncomeTaxesScheduleOfTemporaryDifferencesForWhichDeferredTaxAssetsNotRecognisedDetails Income Taxes - Schedule of temporary differences for which deferred tax assets not recognised (Details) Details 92 false false R93.htm 0094 - Disclosure - Income Taxes - Schedule of non-capital loss carryforwards (Details) Sheet http://www.fsdpharma.com/role/IncomeTaxesScheduleOfNoncapitalLossCarryforwardsDetails Income Taxes - Schedule of non-capital loss carryforwards (Details) Details 93 false false R94.htm 0095 - Disclosure - Commitments and contingencies (Narrative) (Details) Sheet http://www.fsdpharma.com/role/CommitmentsAndContingenciesNarrativeDetails Commitments and contingencies (Narrative) (Details) Details http://www.fsdpharma.com/role/CommitmentsAndContingencies 94 false false R95.htm 0097 - Disclosure - Related party transactions (Narrative) (Details) Sheet http://www.fsdpharma.com/role/RelatedPartyTransactionsNarrativeDetails Related party transactions (Narrative) (Details) Details http://www.fsdpharma.com/role/RelatedPartyTransactionsTables 95 false false R96.htm 0098 - Disclosure - Related party transactions - Schedule of key management personnel compensation (Details) Sheet http://www.fsdpharma.com/role/RelatedPartyTransactionsScheduleOfKeyManagementPersonnelCompensationDetails Related party transactions - Schedule of key management personnel compensation (Details) Details 96 false false R97.htm 0099 - Disclosure - Capital management (Narrative) (Details) Sheet http://www.fsdpharma.com/role/CapitalManagementNarrativeDetails Capital management (Narrative) (Details) Details 97 false false R98.htm 0100 - Disclosure - Subsequent events (Narrative) (Details) Sheet http://www.fsdpharma.com/role/SubsequentEventsNarrativeDetails Subsequent events (Narrative) (Details) Details http://www.fsdpharma.com/role/SubsequentEvents 98 false false All Reports Book All Reports [dq-0526-EntityCommonStockSharesOutstanding-Missing] Submission type 20-F should have a non-empty value for EntityCommonStockSharesOutstanding in the Required Context (one class of stock axis). form20f.htm form20f.htm exhibit12-1.htm exhibit12-2.htm exhibit13-1.htm exhibit13-2.htm exhibit15-1.htm exhibit2-1.htm exhibit4-18.htm exhibit4-19.htm exhibit4-20.htm exhibit8-1.htm huge-20221231.xsd huge-20221231_cal.xml huge-20221231_def.xml huge-20221231_lab.xml huge-20221231_pre.xml form20fxz001.jpg form20fxz002.jpg http://xbrl.sec.gov/dei/2022 https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full true true